|Articles|October 1, 2011
- Pharmaceutical Executive-10-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Advertisement
Articles in this issue
almost 15 years ago
Y. K Hamied : Changing the Dialoguealmost 15 years ago
Fred Frank: Fortune and the Financieralmost 15 years ago
Marck McLellan: An 'A' for Advancing Expectationsalmost 15 years ago
Inside the Mind of the CEO: Steve Collisalmost 15 years ago
Atsushi Nagahisa: Creating Customer Valuealmost 15 years ago
Physicians: Still the Vital Connection in Medicinealmost 15 years ago
Henry Waxman: "Representing" Healthcare to the Fullestalmost 15 years ago
IP: Securing a Global Consensus—Can Industry Do It Again?almost 15 years ago
In Establishing the Evidence Base, He Made Science Countalmost 15 years ago
Jane Henney: Lessons from the FDA Front LineAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5